Daily Briefing: High-Fructose Corn Syrup Keeps its Name
What's in a Name? Rosie Mestel weighs in on the FDA decision to turn down the Corn Refiners Association's petition to rename high fructose corn syrup as "corn sugar, writing for the Los Angeles Times Booster Shot Blog. According to the FDA, the change would confuse consumers and "pose a public health concern."
More Big Gulps on Proposed NY Soda Ban: The mainstream media and the blogosphere took up in earnest the news that New York Mayor Michael Bloomberg plans to ban the sale of sugary drinks of more than 16 ounces sold in movie theaters, sports venues and street stalls. Opinions on the topic ranged from the wonky to outraged.
California's Health Exchange: California took a step closer to implementing its health-care exchange, awarding a contract to build this signature feature of the Affordable Care Act, the Sacramento Bee reports.
Cancer: Cancer cases are expected to rise by more than 75% by 2030 reports Kate Kelland from Reuters. The rise will be sharper in developing countries as they adopt "westernized" lifestyles, according to a World Health Organization study.
Pricing: A Thomson Reuters-NPR Health Poll found that more Americans are seeking pricing information before receiving healthcare and that the information they find influences their choice of provider.
Junk Food: According to a study published in the American Journal of Clinical Nutrition, reducing junk food options does not reduce the overall calorie load that a person takes nor does it help them lose weight reports Reuter's Kerry Grens.
Cancer Treatment: A new class of cancer drugs that may be more effective and less toxic than many existing treatments is being developed, reports Andrew Pollack from the New York Times. The results of an important clinical trial of this type of drugs is expected to attract attention at the annual meeting of the American Society of Clinical Oncology in Chicago.
Photo credit: The Library of Congress via Flickr